SCHEMBL22949587

SCHEMBL22949587

Cc1ccc([Si]2(c3ccc(C)cc3)c3ccccc3-c3cc(-c4nc(-c5ccccc5)nc(-c5ccc6ccccc6c5)n4)ccc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTRC Q99895 1/20 0.41
ALDH1A1 P00352 4/20 0.39
CYP1A2 P05177 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HSD17B10 Q99714 2/20 0.39
HPGD P15428 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
TSHR P16473 1/20 0.39
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
KDM4E B2RXH2 2/20 0.37
TP53 P04637 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
NPC1 O15118 4/20 0.35
RAB9A P51151 4/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
NR1H2 P55055 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22947232 0.93 CTRC (0.41) CTRCALDH1A1CYP1A2SMN1; SMN2HSD17B10
SCHEMBL22947411 0.93 L3MBTL1 (0.39) ALDH1A1CYP1A2SMN1; SMN2HPGDMEN1
SCHEMBL22949534 0.93 L3MBTL1 (0.39) ALDH1A1CYP1A2SMN1; SMN2HPGDMEN1
SCHEMBL22947257 0.92 CTRC (0.49) CTRCALDH1A1CYP1A2SMN1; SMN2HSD17B10
SCHEMBL22947284 0.91 MEN1 (0.41) CTRCALDH1A1CYP1A2SMN1; SMN2HSD17B10
SCHEMBL22948106 0.89 L3MBTL1 (0.36) ALDH1A1CYP1A2HPGDMEN1KMT2A
SCHEMBL22947272 0.89 MEN1 (0.37) ALDH1A1CYP1A2SMN1; SMN2HPGDMEN1
SCHEMBL23869125 0.89 MEN1 (0.40) ALDH1A1CYP1A2SMN1; SMN2HSD17B10HPGD
SCHEMBL22949564 0.88 HPRT1 (0.36) ALDH1A1CYP1A2SMN1; SMN2HSD17B10HPGD
SCHEMBL22949590 0.87 CTRC (0.39) CTRCALDH1A1CYP1A2SMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210036245-A1 HETEROAROMATIC COMPOUNDS MERCK PATENT GMBH (DE) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036245-A1 HETEROAROMATIC COMPOUNDS ETV6, FES, LEF1 CTRC 2608/4885ALDH1A1 752/4885CYP1A2 281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.